EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark CSL SEQIRUS was filed as Word mark on 08/10/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 12/10/2022.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018746220 |
| Application date | August 10, 2022 |
| Publication date | September 2, 2022 |
| Entry date | December 10, 2022 |
| Expiration date | August 10, 2032 |
Trademark owner
Point, 29 Market Street
SL6 8AA Maidenhead
GB
SL6 8AA Maidenhead
GB
Trademark representatives
Claude Debussylaan 54
1082 MD Amsterdam
NL
goods and services
1
Chemical and biological reagents in this class; cell cultures and media in this class; laboratory and scientific test kits in this class; chemical preparations for scientific and/or industrial purposes; diagnostic and testing agents; chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells; none of the aforesaid goods being for the gut-brain-skin axis application, and / or alimentary tract wellbeing and/or prevention and treatment of digestive system diseases, and / or prevention and treatment of urogenital tract diseases, and / or skin nutrition, protection and treatment
5
Pharmaceutical preparations and substances in this class; vaccines; blood products; products derived from blood and products derived from recombinant DNA technology; serums; antibodies; medical and veterinary test kits; influenza vaccines; adjuvants and antigens; pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders; blood products, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; none of the aforesaid goods being for the gut-brain-skin axis application, and / or alimentary tract wellbeing and/or prevention and treatment of digestive system diseases, and / or prevention and treatment of urogenital tract diseases, and / or skin nutrition, protection and treatment
41
Education services including medical education services; health education; consultancy services relating to education; provision of education services via an online forum; provision of training and education courses; publication of educational materials; dissemination of educational material; weblog (blog) services; electronic publication of information on a wide range of topics, including online and over a global computer network
42
Scientific and technological services; research and development services, including scientific, medical, pharmaceutical and blood products research and development services; industrial analysis; clinical trials; conducting clinical trials; provision of testing facilities; rental of research facilities; laboratory analysis and research; management of scientific research projects; preparation of technical studies, technical reports, scientific reports; management of scientific research projects, preparation of scientific and medical research projects, preparation of statistics or reports relating to scientific and medical research; provision of research services and facilities, provision of research results, information and outcomes; provision of information relating to the aforementioned services; advisory and consultancy services relating to the aforementioned services; dissemination of information relating to the aforementioned services over a global computer network; medical laboratory services, namely, scientific testing and screening services, namely, testing of human blood plasma for safety and quality; medical laboratory services regarding human blood plasma
44
Medical services; medical information services; health care services; health care information services; patient support services; providing medical information concerning blood products; providing medical information concerning vaccines, anti-venoms and immunohaematology products, namely, diagnostic reagents; patient support services, namely, providing patient medical information where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community via an Internet-based database
ID: 11018746220